# Continuous Intravenous Lidocaine Infusion Versus Placebo for Rib Fracture Analgesia

> **NCT04140396** · PHASE4 · TERMINATED · sponsor: **Stanford University** · enrollment: 1 (actual)

## Conditions studied

- Rib Fractures

## Interventions

- **DRUG:** Saline infusion
- **DRUG:** Lidocaine infusion

## Key facts

- **NCT ID:** NCT04140396
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-10
- **Primary completion:** 2020-11-09
- **Final completion:** 2020-11-09
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Lack of personnel and lack of funding for the study drug
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04140396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04140396, "Continuous Intravenous Lidocaine Infusion Versus Placebo for Rib Fracture Analgesia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04140396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*